“We see a big pile of demand coming through for big boxes and automated sheds,” said Greg Goodman as Goodman Group beat earnings guidance and ramped up development.
Announcing results for the year ended 31 March 2021, Belfast-based Fusion Antibodies, providers of solutions for the drug and diagnostics markets, were optimistic about the progress of their platform approach for antibodies optimisation. Click to read more.